Logo image of CTRM

CASTOR MARITIME INC (CTRM) Stock Fundamental Analysis

NASDAQ:CTRM - Nasdaq - MHY1146L2082 - Common Stock - Currency: USD

2.28  +0.01 (+0.44%)

After market: 2.2997 +0.02 (+0.86%)

Fundamental Rating

3

Overall CTRM gets a fundamental rating of 3 out of 10. We evaluated CTRM against 33 industry peers in the Marine Transportation industry. CTRM has an average financial health and profitability rating. CTRM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year CTRM was profitable.
In the past year CTRM had a positive cash flow from operations.
Of the past 5 years CTRM 4 years were profitable.
CTRM had a positive operating cash flow in 4 of the past 5 years.
CTRM Yearly Net Income VS EBIT VS OCF VS FCFCTRM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

CTRM's Return On Assets of 4.24% is in line compared to the rest of the industry. CTRM outperforms 51.52% of its industry peers.
CTRM has a Return On Equity (5.93%) which is comparable to the rest of the industry.
CTRM has a Return On Invested Capital of 0.16%. This is in the lower half of the industry: CTRM underperforms 72.73% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CTRM is below the industry average of 7.92%.
Industry RankSector Rank
ROA 4.24%
ROE 5.93%
ROIC 0.16%
ROA(3y)9.69%
ROA(5y)7.09%
ROE(3y)12.95%
ROE(5y)9.46%
ROIC(3y)4.08%
ROIC(5y)4.6%
CTRM Yearly ROA, ROE, ROICCTRM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

1.3 Margins

CTRM's Profit Margin of 51.03% is amongst the best of the industry. CTRM outperforms 90.91% of its industry peers.
In the last couple of years the Profit Margin of CTRM has grown nicely.
Looking at the Operating Margin, with a value of 2.26%, CTRM is doing worse than 75.76% of the companies in the same industry.
CTRM's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 58.78%, CTRM is in the better half of the industry, outperforming 69.70% of the companies in the same industry.
In the last couple of years the Gross Margin of CTRM has grown nicely.
Industry RankSector Rank
OM 2.26%
PM (TTM) 51.03%
GM 58.78%
OM growth 3Y-65.28%
OM growth 5Y-37.53%
PM growth 3Y9%
PM growth 5Y22.86%
GM growth 3Y-7.34%
GM growth 5Y2.08%
CTRM Yearly Profit, Operating, Gross MarginsCTRM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CTRM is destroying value.
CTRM has about the same amout of shares outstanding than it did 1 year ago.
CTRM has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CTRM has an improved debt to assets ratio.
CTRM Yearly Shares OutstandingCTRM Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CTRM Yearly Total Debt VS Total AssetsCTRM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

CTRM has an Altman-Z score of 0.83. This is a bad value and indicates that CTRM is not financially healthy and even has some risk of bankruptcy.
CTRM has a Altman-Z score of 0.83. This is comparable to the rest of the industry: CTRM outperforms 48.48% of its industry peers.
A Debt/Equity ratio of 0.16 indicates that CTRM is not too dependend on debt financing.
CTRM has a Debt to Equity ratio of 0.16. This is in the better half of the industry: CTRM outperforms 78.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 0.83
ROIC/WACC0.03
WACC5.23%
CTRM Yearly LT Debt VS Equity VS FCFCTRM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 3.94 indicates that CTRM has no problem at all paying its short term obligations.
CTRM's Current ratio of 3.94 is amongst the best of the industry. CTRM outperforms 87.88% of its industry peers.
CTRM has a Quick Ratio of 3.92. This indicates that CTRM is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CTRM (3.92) is better than 87.88% of its industry peers.
Industry RankSector Rank
Current Ratio 3.94
Quick Ratio 3.92
CTRM Yearly Current Assets VS Current LiabilitesCTRM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

2

3. Growth

3.1 Past

CTRM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -49.74%.
The earnings per share for CTRM have been decreasing by -53.56% on average. This is quite bad
Looking at the last year, CTRM shows a very negative growth in Revenue. The Revenue has decreased by -32.07% in the last year.
The Revenue has been growing by 61.83% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-49.74%
EPS 3Y-43.17%
EPS 5Y-53.56%
EPS Q2Q%-408.82%
Revenue 1Y (TTM)-32.07%
Revenue growth 3Y-13.62%
Revenue growth 5Y61.83%
Sales Q2Q%-38.69%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CTRM Yearly Revenue VS EstimatesCTRM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 2.53 indicates a rather cheap valuation of CTRM.
Compared to the rest of the industry, the Price/Earnings ratio of CTRM indicates a rather cheap valuation: CTRM is cheaper than 87.88% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.34. CTRM is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 2.53
Fwd PE N/A
CTRM Price Earnings VS Forward Price EarningsCTRM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -6.09
CTRM Per share dataCTRM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CTRM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CASTOR MARITIME INC

NASDAQ:CTRM (6/23/2025, 5:09:55 PM)

After market: 2.2997 +0.02 (+0.86%)

2.28

+0.01 (+0.44%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryMarine Transportation
Earnings (Last)02-13 2025-02-13
Earnings (Next)06-25 2025-06-25
Inst Owners4.24%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap22.02M
Analysts0
Price TargetN/A
Short Float %0.66%
Short Ratio1.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.26
Dividend Growth(5Y)N/A
DP7.4%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.53
Fwd PE N/A
P/S 0.33
P/FCF N/A
P/OCF 0.53
P/B 0.04
P/tB 0.04
EV/EBITDA -6.09
EPS(TTM)0.9
EY39.47%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-3.13
FCFYN/A
OCF(TTM)4.34
OCFY190.29%
SpS6.86
BVpS59.02
TBVpS55.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.24%
ROE 5.93%
ROCE 0.2%
ROIC 0.16%
ROICexc 0.2%
ROICexgc 0.22%
OM 2.26%
PM (TTM) 51.03%
GM 58.78%
FCFM N/A
ROA(3y)9.69%
ROA(5y)7.09%
ROE(3y)12.95%
ROE(5y)9.46%
ROIC(3y)4.08%
ROIC(5y)4.6%
ROICexc(3y)5.13%
ROICexc(5y)5.44%
ROICexgc(3y)5.14%
ROICexgc(5y)5.45%
ROCE(3y)5.16%
ROCE(5y)5.82%
ROICexcg growth 3Y-73.03%
ROICexcg growth 5Y-46.26%
ROICexc growth 3Y-73.62%
ROICexc growth 5Y-46.97%
OM growth 3Y-65.28%
OM growth 5Y-37.53%
PM growth 3Y9%
PM growth 5Y22.86%
GM growth 3Y-7.34%
GM growth 5Y2.08%
F-Score4
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA 5.6
Cap/Depr 479.96%
Cap/Sales 108.95%
Interest Coverage 0.47
Cash Conversion 253.53%
Profit Quality N/A
Current Ratio 3.94
Quick Ratio 3.92
Altman-Z 0.83
F-Score4
WACC5.23%
ROIC/WACC0.03
Cap/Depr(3y)296.8%
Cap/Depr(5y)1001.35%
Cap/Sales(3y)53.29%
Cap/Sales(5y)134.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.74%
EPS 3Y-43.17%
EPS 5Y-53.56%
EPS Q2Q%-408.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-32.07%
Revenue growth 3Y-13.62%
Revenue growth 5Y61.83%
Sales Q2Q%-38.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-90.44%
EBIT growth 3Y-70.01%
EBIT growth 5Y1.09%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-172.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.6%
OCF growth 3Y-11.65%
OCF growth 5Y78.51%